-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017188-mold-final-report-2010.pdf
January 01, 2010 - A greater proportion of Portal users adhered to recommendations about aspirin use
(78.6% intervention … Compared to the control group, a greater
proportion of Portal users adhered to recommendations about aspirin … Compared to the control group, a greater proportion of Portal users adhered to
recommendations about aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year5-final-report-2021.pdf
January 01, 2021 - Yes
Abnormal Blood Glucose and Type
2 Diabetes Mellitus: Part Two,
Counseling
No Yes Yes Yes
Aspirin … abnormal-blood-glucose-and-type-2-diabetes-mellitus-part-two-counseling
https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
January 01, 2017 - For systemic administration of salicylates, non-acetylated and aspirin are treated separately. … For aspirin, doses greater than
100mg/day are of concern.
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024541-goss-final-report-2018.pdf
January 01, 2018 - For example, while aspirin
is a highly relevant item for chest pain, aspirin prescriptions rarely contain
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs022701-ornstein-final-report-2014.pdf
January 01, 2014 - ) who
were prescribed beta-blocker therapy
57.9 14.0
Ischemic Vascular
Disease (IVD): Use of
Aspirin … of age and older with diagnosis of ischemic vascular
disease (IVD) who had documentation of use of aspirin … 96.5 (13.9) 54.7 (22.1) 56.2*† (27.2) N/A 48.0† (24.8)
Ischemic Vascular Disease
(IVD): Use of Aspirin
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015196-crandall-final-report-2007.pdf
January 01, 2007 - were all AMI
measures that show mean defect rates of < 9% over the entire 18 month period: AMI 1 - Aspirin … at Arrival; AMI 2 - Aspirin Prescribed at Discharge; AMI 3 - ACE Inhibitor/ARB for LVSD;
AMI 5 - Beta … efficacy as
there were 3 months in which the defect rates were reduced to zero – once for AMI 2 -
Aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026257-friedman-final-report-2020.pdf
January 01, 2020 - cancer screening; CRC screening; HIV screening; HTN screening; Alcohol misuse;
Tobacco cessation; Aspirin … AAA Abdominal aortic aneurysm screening
ALC Alcohol use: reduce to healthy levels
ASA Aspirin use
-
digital.ahrq.gov/sites/default/files/docs/page/findings-and-lessons-from-clinical-decision-support-demonstration-projects.pdf
June 01, 2014 - Disease
American College of Cardiology Guideline for
Anti-platelet Therapy & USPSTF
Recommendation on Aspirin … Disease
American College of Cardiology Guideline for
Anti-platelet Therapy & USPSTF
Recommendation on Aspirin … Disease
American College of Cardiology Guideline for
Anti-platelet Therapy & USPSTF
Recommendation on Aspirin … *
American College of Cardiology Guideline for
Anti-platelet Therapy & USPSTF
Recommendation on Aspirin
-
digital.ahrq.gov/sites/default/files/docs/CDS%20to%20MonitorImprove%20PopHealth+Nov%2018_Final.pdf
January 01, 2018 - improving quality of
care for measures that matter
• People at increased risk of CVD who are taking
aspirin
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015431-brooks-final-report-2007.pdf
January 01, 2007 - failure and pneumonia measures, the ‘all condition’ composite
included five AMI process measures (aspirin … at arrival; aspirin at
discharge; ACEI or ARB for LVSD; beta blockers at arrival; beta blockers
at
-
digital.ahrq.gov/sites/default/files/docs/page/medicaid_medical_home_initiatives_and_the_role_of_health_information_technology_5.pdf
January 01, 2010 - PPC-PCMH Recognition
12
SEPA Diabetes Clinical Outcomes
• Reduced HgA1c and LDL levels
• Improved aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year1-final-report.pdf
October 01, 2017 - Further, the USPSTF had
recommendations on aspirin use. … cholesterol management:
• ACC/AHA statin therapy recommendation statements
• USPSTF statin therapy and aspirin … IP
Approval
USPSTF Statin Use for Primary Prevention of CVD in
Adults
Structured Yes
USPSTF Aspirin
-
digital.ahrq.gov/sites/default/files/docs/20070112%20First_Consulting_Tool.pdf
January 12, 2007 - who admits a patient with
acute myocardial infarction to remind the patient that they don't get
Aspirin … patient has an acute myocardial infarction, does it remind the care
providers that the patient is on aspirin
-
digital.ahrq.gov/sites/default/files/docs/better-medication-management-slides-021611.pdf
February 16, 2011 - changes,
– two-thirds of substitutions inappropriate or dangerous
» Heparin + coumadin, clopidogrel + aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026322-dorsch-final-report-2021.pdf
January 01, 2021 - For example, remove
aspirin/NSAIDs or treat hypertension.
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs017191-pohl-final-report-2011.pdf
January 01, 2011 - smokers offered cessation intervention
• % taking ACE Inhibitor or ARB
• % taking Statins
• % taking Aspirin … ; self-management goal;
taking ACE inhibitors or ARBs; on Statins; blood pressure measured; taking Aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year6-final-report-2022.pdf
January 01, 2022 - Yes
Abnormal Blood Glucose and Type 2
Diabetes Mellitus: Part Two,
Counseling
Yes Yes Yes Yes
Aspirin … Notably, the update for the
Aspirin Therapy for Primary Prevention of CVD and Colorectal Cancer was
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017855-friedman-final-report-2013.pdf
January 01, 2013 - sometimes address issues that are not significant (such as a patient
taking an additional dose of aspirin … It was reiterated that taking an extra dose of aspirin or
Prilosec is not going to harm a patient.
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015226-gandhi-final-report-2008.pdf
January 01, 2008 - Chronic Disease Management Reminders and Guidelines: CAD—Beta blocker and
aspirin use
α
II.
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017034-chrischilles-final-report-2011.pdf
January 01, 2011 - 207 (25.8%) 66 (24.2%) 0.5920 164 (20.4%) 53 (19.4%) 0.7129
Taking 2 or more NSAIDS
(including aspirin … 33.3%)* 164 (24.4%) 35 (27.1%)* 129 (19.2%) 1.24 (0.69 , 2.24)
Taking 2 or more NSAIDs (including
aspirin